IP Library Granted Patent US 12,201,704
Granted Patent B2
US 12,201,704 · App. 17/329,428 · Granted Jan 21, 2025

System and method for treating skin and areas proximate thereto

Inventor: Allan Danto (Cardiff, CA)
A61K8/0204A61B17/3203A61B17/50A61B17/545A61B50/13A61K8/19A61K8/20A61K8/26A61M37/0092A61N5/0616A61N5/062A61N5/0624A61Q19/08A61B2017/00747A61B2017/00761A61B2017/320004A61B2017/32035A61B2217/005A61B2218/007A61K2800/28A61K2800/87A61M2037/0007A61N2005/0652A61N2005/0659A61N2005/0663
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,201,704
App. No.
17/329,428
Granted
Jan 21, 2025
Kind
B2
Abstract

A system and method for treating skin and areas proximate thereto, preferably using at least one of an exfoliant, a transducer operating at a frequency ranging from approximately 20 kHz to approximately 250 MHz, and/or a light source having a predominant wavelength ranging from approximately 400 nm to approximately 2,500 nm.

Claims (22)

1. A system for treating skin and areas proximate thereto, comprising:

a first component, wherein the first component is a first hand piece adapted for treatment of skin using a skin exfoliating abrasive;

a second component, wherein the second component is separate from the first component and is a transducer for treatment of skin;

an optional third component, wherein the optional third component is separate from the first and second components and is an adjustable lamp that emits light having a wavelength ranging from 400 nm to 2,940 nm;

a single air pressure source providing positive pressure;

at least one of a controller and a regulator for controlling a pressure value of pressurized air from the air pressure source;

an output tube for collecting waste from a skin treatment site; and

a positive pressure-to-vacuum generating eductor coupled to the output tube.

2. The system according to claim 1 , wherein the exfoliating abrasive comprises sodium chloride.

3. The system according to claim 1 , wherein the exfoliating abrasive comprises aluminum oxide.

4. The system according to claim 1 , wherein the exfoliating abrasive comprises sodium bicarbonate.

5. The system according to claim 1 , wherein the exfoliating abrasive comprises saline.

6. The system according to claim 1 , wherein the transducer operates at a frequency ranging from approximately 20 kHz to approximately 250 MHz.

7. The system according to claim 1 , wherein the transducer operates at a frequency of at least one of 20 KHz, 50 kHz, 100 kHz, 500 KHz, 1 MHZ, 2 MHZ, 3 MHZ, 3.3 MHz, 5 MHZ, 7.5 MHZ, 8 MHZ, 10 , MHz, 12 MHZ, 15 MHZ, 20 MHZ, 50 MHZ, 100 MHZ, 200 MHz, and 250 MHz.

8. A system for treating skin and areas proximate thereto, comprising:

a first component, wherein the first component is a first hand piece adapted for treatment of skin using a skin exfoliating abrasive;

a second component, wherein the second component is separate from the first component and is a transducer for treatment of skin;

an optional third component, wherein the optional third component is separate from the first and second components and is an adjustable lamp that emits light having a wavelength ranging from 400 nm to 2,940 nm;

a single air pressure source providing positive pressure;

at least one of a controller and a regulator for controlling a pressure value of pressurized air from the air pressure source;

an output tube for collecting waste from a skin treatment site;

a positive pressure-to-vacuum generating eductor coupled to the output tube; and wherein the system for treating skin is adapted to direct an abrasive under positive pressure onto tissue through an angled handpiece having an angle of impingement of between approximately 20°-50°.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 5, 2026
From: LESLIE T. GLADSTONE, DBA FINANCIAL FIDUCIARIES
To: MICRO IMAGING TECHNOLOGY INC.
Reel/Frame 073366/0496 →
SECURITY INTEREST Recorded Sep 16, 2025
From: MED-AESTHETIC SOLUTIONS, INC.
To: KING, WILLIAM L., III, MR.
Reel/Frame 072869/0351 →
SECURITY INTEREST Recorded Sep 11, 2025
From: MED-AESTHETIC SOLUTIONS, INC. DBA SALTMED
To: KING & PARTNERS, PLC
Reel/Frame 072856/0391 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 4, 2025
From: DANTO, ALLAN
To: MED-AESTHETIC SOLUTIONS, INC.
Reel/Frame 072159/0109 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 4, 2025
From: MED-AESTHETIC SOLUTIONS, INC.
To: LESLIE T. GLADSTONE DBA FINANCIAL FIDUCIARIES
Reel/Frame 072159/0304 →
Continuity (4)
Continuation In Part 17069288 · Oct 13, 2020
Continuation 16081374
Provisional Application 62494005 · Jul 25, 2016
Related Publication 20210275406A1 · Sep 9, 2021
References Cited (43)
US 3930505A · Wallach · 1976 [cited by applicant]
US 5037432A · Molinari · 1991 [cited by applicant]
US 5207234A · Rosso · 1993 [cited by applicant]
US 5441490A · Svedman · 1995 [cited by applicant]
US 5971999A · Naldoni · 1999 [cited by applicant]
US 5980512A · Silberg · 1999 [cited by applicant]
US 6375635B1 · Moutafis · 2002 [cited by applicant]
US 6511493B1 · Moutafis · 2003 [cited by applicant]
US 6562050B1 · Owen · 2003 [cited by applicant]
US 6615014B2 · Sugihara · 2003 [cited by applicant]
US 6726693B2 · Weber et al. · 2004 [cited by applicant]
US 6764493B1 · Weber et al. · 2004 [cited by applicant]
US 7179477B2 · Gupta · 2007 [cited by applicant]
US 7532926B2 · Bernabei · 2009 [cited by applicant]
US 8518031B2 · Boyden et al. · 2013 [cited by applicant]
US 8814836B2 · Ignon et al. · 2014 [cited by applicant]
US 9308024B2 · Whyte et al. · 2016 [cited by applicant]
US 9642997B2 · Ignon et al. · 2017 [cited by applicant]
US 9649131B2 · Beijens et al. · 2017 [cited by applicant]
US 10172644B2 · Ignon et al. · 2019 [cited by applicant]
US 10556097B2 · Ignon et al. · 2020 [cited by applicant]
US 10799430B2 · Danto · 2020 [cited by applicant]
US 20010023351A1 · Eilers et al. · 2001 [cited by applicant]
US 20020058952A1 · Weber et al. · 2002 [cited by applicant]
US 20020188261A1 · Hruska · 2002 [cited by applicant]
US 20030212415A1 · Karasiuk · 2003 [cited by applicant]
US 20040092920A1 · Rozenshpeer · 2004 [cited by applicant]
US 20040219179A1 · McDaniel · 2004 [cited by applicant]
US 20060229550A1 · Staid et al. · 2006 [cited by applicant]
US 20070065515A1 · Key · 2007 [cited by applicant]
US 20100152880A1 · Boyden et al. · 2010 [cited by applicant]
US 20100228273A1 · Staid et al. · 2010 [cited by applicant]
US 20100298760A1 · Olle et al. · 2010 [cited by applicant]
US 20110224691A1 · Whyte et al. · 2011 [cited by applicant]
US 20120029499A1 · Bernabei · 2012 [cited by applicant]
US 20160008031A1 · Beijens et al. · 2016 [cited by applicant]
US 20160038183A1 · Ignon et al. · 2016 [cited by applicant]
US 20190091113A1 · Danto · 2019 [cited by applicant]
US 20210128416A1 · Danto · 2021 [cited by applicant]
US 20210275406A1 · Danto · 2021 [cited by applicant]
WO WO2000049953 · 2000 [cited by applicant]
WO WO2018022517 · 2018 [cited by applicant]
Written Opinion for International Application No. PCT/US17/43546 dated Oct. 12, 2017. [cited by applicant]